Jennifer L. McNeer to Antineoplastic Agents
This is a "connection" page, showing publications Jennifer L. McNeer has written about Antineoplastic Agents.
Connection Strength
0.397
-
Toxicity from asparaginase during acute lymphoblastic leukemia induction: a report from the Children's Oncology Group. Blood Adv. 2026 07 28; 10(14):4923-4930.
Score: 0.111
-
Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia. Cancer Med. 2021 11; 10(21):7551-7560.
Score: 0.079
-
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Leukemia. 2019 04; 33(4):884-892.
Score: 0.064
-
Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study. Cancer. 2017 Jan 01; 123(1):122-130.
Score: 0.056
-
Pediatric Acute Lymphoblastic Leukemia: From Diagnosis to Prognosis. Pediatr Ann. 2015 Jul; 44(7):e168-74.
Score: 0.051
-
Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide. J Biol Chem. 2010 Sep 24; 285(39):29989-97.
Score: 0.036